Literature DB >> 12485619

Non-apoptotic Fas signaling.

Harald Wajant1, Klaus Pfizenmaier, Peter Scheurich.   

Abstract

Fas (Apo-1, CD95) and Fas-Ligand (FasL, CD95L) are typical members of the TNF receptor and TNF ligand family, respectively, with a pivotal role in the regulation of apoptotic processes, including activation-induced cell death, T-cell-induced cytotoxicity, immune privilege and tumor surveillance. Impairment of the FasL/Fas system has been implicated in liver failure, autoimmune diseases and immune deficiency. Thus, the FasL/Fas system was mainly appreciated with respect to its death-inducing capabilities. However, there is increasing evidence that activation of Fas can also result in non-apoptotic responses like cell proliferation or NF-kappaB activation. While the apoptotic features of the FasL/Fas system and the pathways involved are comparably well investigated, the pathways that are utilized by Fas to transduce proliferative and activating signals are poorly understood. This review is focused on the non-apoptotic functions of the FasL/Fas system. In particular, the similarities and differences of the molecular mechanisms of apoptotic and non-apoptotic Fas signaling are addressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12485619     DOI: 10.1016/s1359-6101(02)00072-2

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  66 in total

1.  CD95 and CD95L promote and protect cancer stem cells.

Authors:  Paolo Ceppi; Abbas Hadji; Frederick J Kohlhapp; Abhinandan Pattanayak; Annika Hau; Xia Liu; Huiping Liu; Andrea E Murmann; Marcus E Peter
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

2.  Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.

Authors:  Isabell Lang; Andrea Fick; Viktoria Schäfer; Tina Giner; Daniela Siegmund; Harald Wajant
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Modulation of CD4+ T-cell activation by CD95 co-stimulation.

Authors:  M Paulsen; S Valentin; B Mathew; S Adam-Klages; U Bertsch; I Lavrik; P H Krammer; D Kabelitz; O Janssen
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

4.  Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients.

Authors:  Milena Nasi; Marcello Pinti; Roberto Bugarini; Leonarda Troiano; Enrico Lugli; Cristian Bellodi; Cristina Mussini; Vanni Borghi; Tommaso Trenti; Fiorella Balli; Roberto Esposito; Andrea Cossarizza
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

Review 5.  Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity.

Authors:  Sabine Adam-Klages; Dieter Adam; Ottmar Janssen; Dieter Kabelitz
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 6.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

7.  Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Authors:  Purvi Mande; Bahar Zirak; Wei-Che Ko; Keyon Taravati; Karen L Bride; Tia Y Brodeur; April Deng; Karen Dresser; Zhaozhao Jiang; Rachel Ettinger; Katherine A Fitzgerald; Michael D Rosenblum; John E Harris; Ann Marshak-Rothstein
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

8.  Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

Authors:  Akihiro Hasegawa; Xin Cheng; Kiichi Kajino; Alan Berezov; Kaoru Murata; Toshinori Nakayama; Hideo Yagita; Ramachandran Murali; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

9.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.

Authors:  Stephan Wueest; Reto A Rapold; Desiree M Schumann; Julia M Rytka; Anita Schildknecht; Ori Nov; Alexander V Chervonsky; Assaf Rudich; Eugen J Schoenle; Marc Y Donath; Daniel Konrad
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  Relationship between apoptotic markers in semen from fertile men and demographic, hormonal and seminal characteristics.

Authors:  Ina O Specht; Marcello Spanò; Karin S Hougaard; Gian C Manicardi; Davide Bizzaro; Gunnar Toft; Aleksander Giwercman; Jens-Peter E Bonde
Journal:  Asian J Androl       Date:  2012-10-15       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.